News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Acambis PLC - Update On MVA Procurement
July 26, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Acambis plc ("Acambis") (LSE: ACM, NASDAQ: ACAM) provides an update on the US Government tender process relating to Modified Vaccinia Ankara ("MVA") attenuated smallpox vaccine.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Europe
MORE ON THIS TOPIC
Tariffs
Trump Administration Settles on 15% Generic Drug Tariff Rate for EU
August 22, 2025
·
1 min read
·
Annalee Armstrong
Approvals
Ionis Wins Approval For First RNA-Targeted Prophylactic for Rare Swelling Disease
August 22, 2025
·
2 min read
·
Tristan Manalac
Regulatory
After Court Win, Vanda Asks Makary To Review ‘Unacceptable’ Approval of Rival Generics
August 22, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Krystal Cuts Melanoma Study of Viral Immunotherapy as FDA ‘Uncertainty’ Muddies Approval Pathway
August 22, 2025
·
2 min read
·
Tristan Manalac
